MyFinsight
Home
About
Contact
derm: the income statement
Download
Download image
Net loss
-$2,315K
(3.14%↑ Y/Y)
Other Legacy
$701K
Foam Franchise
Products Amzeeq Zilxi
$1,311K
Accutane
$2,769K
Qbrexza
$7,361K
Emrosi
$4,883K
Loss before income
taxes
-$2,315K
(3.14%↑ Y/Y)
Total other revenues
$606K
Product revenue, net
$17,025K
(16.38%↑ Y/Y)
Total other expense
(income)
-$786K
(-255.95%↓ Y/Y)
Loss from operations
-$1,529K
(47.17%↑ Y/Y)
Interest income
$154K
(-18.09%↓ Y/Y)
Total revenue
$17,631K
(20.52%↑ Y/Y)
Foreign exchange
transaction losses
-$3K
(94.12%↑ Y/Y)
Interest expense
$937K
(23.61%↑ Y/Y)
Total operating
expenses
$19,160K
(9.34%↑ Y/Y)
Selling, general and
administrative
$12,054K
(5.77%↑ Y/Y)
Research and development
$287K
(-65.91%↓ Y/Y)
Amortization of acquired
intangible assets
$1,064K
Cost of goods sold -
(excluding amortization of...
$5,755K
Back
Back
Income Statement
source: myfinsight.com
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)